Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.

@article{Hudson1998FluvoxamineIT,
  title={Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.},
  author={James I. Hudson and Susan L McElroy and Nancy C. Raymond and Scott J Crow and Paul E. Keck and William P Carter and James E. Mitchell and Stephen M Strakowski and Harrison Graham Pope and Bronwen S Coleman and Jeffrey M Jonas},
  journal={The American journal of psychiatry},
  year={1998},
  volume={155 12},
  pages={1756-62}
}
OBJECTIVE The purpose of this study was to assess the efficacy of fluvoxamine in the treatment of binge-eating disorder. Binge-eating disorder is a newly described eating disorder characterized by recurrent episodes of binge eating but without purging behaviors. Uncontrolled reports have suggested that serotonin selective reuptake inhibitors (SSRIs) may be effective in treating this disorder. METHOD Eighty-five outpatients with a DSM-IV diagnosis of binge-eating disorder were randomly… CONTINUE READING
50 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 50 extracted citations

Similar Papers

Loading similar papers…